Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
16
pubmed:dateCreated
2009-10-28
pubmed:abstractText
In the prostate, androgens play a crucial role in normal and cancerous growth; hence the androgenic pathway has become a target of therapeutic intervention. Dutasteride is a 5 alpha-reductase (5AR) inhibitor currently being evaluated both for chemoprevention and treatment of prostate cancer. Dutasteride inhibits both 5AR I and II enzymes, effectively blocking conversion of testosterone to dihydrotestosterone (DHT) in the prostate. This greatly reduces the amount of the active ligand DHT available for binding to the androgen receptor (AR) and stimulating proliferation, making this a good candidate for chemoprevention of prostate cancer. In this study, we sought to determine how dutasteride is functioning at the molecular level, using a prostate cancer xenograft model.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19676081-12429629, http://linkedlifedata.com/resource/pubmed/commentcorrection/19676081-12712403, http://linkedlifedata.com/resource/pubmed/commentcorrection/19676081-12925520, http://linkedlifedata.com/resource/pubmed/commentcorrection/19676081-14716738, http://linkedlifedata.com/resource/pubmed/commentcorrection/19676081-15166021, http://linkedlifedata.com/resource/pubmed/commentcorrection/19676081-15371831, http://linkedlifedata.com/resource/pubmed/commentcorrection/19676081-15477368, http://linkedlifedata.com/resource/pubmed/commentcorrection/19676081-16043352, http://linkedlifedata.com/resource/pubmed/commentcorrection/19676081-16384856, http://linkedlifedata.com/resource/pubmed/commentcorrection/19676081-16818707, http://linkedlifedata.com/resource/pubmed/commentcorrection/19676081-17477363, http://linkedlifedata.com/resource/pubmed/commentcorrection/19676081-17573244, http://linkedlifedata.com/resource/pubmed/commentcorrection/19676081-17634540, http://linkedlifedata.com/resource/pubmed/commentcorrection/19676081-17636412, http://linkedlifedata.com/resource/pubmed/commentcorrection/19676081-17707058, http://linkedlifedata.com/resource/pubmed/commentcorrection/19676081-18079321, http://linkedlifedata.com/resource/pubmed/commentcorrection/19676081-19164447, http://linkedlifedata.com/resource/pubmed/commentcorrection/19676081-9209391
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1097-0045
pubmed:author
pubmed:copyrightInfo
Copyright 2009 Wiley-Liss, Inc.
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
69
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1730-43
pubmed:dateRevised
2011-5-12
pubmed:meshHeading
pubmed-meshheading:19676081-Androgens, pubmed-meshheading:19676081-Animals, pubmed-meshheading:19676081-Azasteroids, pubmed-meshheading:19676081-Cell Division, pubmed-meshheading:19676081-Cholestenone 5 alpha-Reductase, pubmed-meshheading:19676081-Delayed-Action Preparations, pubmed-meshheading:19676081-Drug Implants, pubmed-meshheading:19676081-Enzyme Inhibitors, pubmed-meshheading:19676081-Gene Expression, pubmed-meshheading:19676081-Male, pubmed-meshheading:19676081-Mice, pubmed-meshheading:19676081-Mice, Inbred BALB C, pubmed-meshheading:19676081-Microarray Analysis, pubmed-meshheading:19676081-Neoplasm Transplantation, pubmed-meshheading:19676081-Prostatic Neoplasms, pubmed-meshheading:19676081-Signal Transduction, pubmed-meshheading:19676081-Transplantation, Heterologous, pubmed-meshheading:19676081-Up-Regulation, pubmed-meshheading:19676081-rho GTP-Binding Proteins
pubmed:year
2009
pubmed:articleTitle
Effects of the 5 alpha-reductase inhibitor dutasteride on gene expression in prostate cancer xenografts.
pubmed:affiliation
Department of Urology Research, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural